1. Home
  2. NVCR vs PHIN Comparison

NVCR vs PHIN Comparison

Compare NVCR & PHIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • PHIN
  • Stock Information
  • Founded
  • NVCR 2000
  • PHIN 2023
  • Country
  • NVCR Switzerland
  • PHIN United States
  • Employees
  • NVCR N/A
  • PHIN N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • PHIN
  • Sector
  • NVCR Health Care
  • PHIN
  • Exchange
  • NVCR Nasdaq
  • PHIN Nasdaq
  • Market Cap
  • NVCR 1.9B
  • PHIN 1.8B
  • IPO Year
  • NVCR 2015
  • PHIN N/A
  • Fundamental
  • Price
  • NVCR $17.44
  • PHIN $41.97
  • Analyst Decision
  • NVCR Buy
  • PHIN Buy
  • Analyst Count
  • NVCR 6
  • PHIN 5
  • Target Price
  • NVCR $32.83
  • PHIN $52.60
  • AVG Volume (30 Days)
  • NVCR 861.0K
  • PHIN 490.9K
  • Earning Date
  • NVCR 04-24-2025
  • PHIN 04-25-2025
  • Dividend Yield
  • NVCR N/A
  • PHIN 2.58%
  • EPS Growth
  • NVCR N/A
  • PHIN N/A
  • EPS
  • NVCR N/A
  • PHIN 1.75
  • Revenue
  • NVCR $621,711,000.00
  • PHIN $3,336,000,000.00
  • Revenue This Year
  • NVCR $2.90
  • PHIN $0.03
  • Revenue Next Year
  • NVCR $10.47
  • PHIN $2.59
  • P/E Ratio
  • NVCR N/A
  • PHIN $23.96
  • Revenue Growth
  • NVCR 18.27
  • PHIN N/A
  • 52 Week Low
  • NVCR $14.17
  • PHIN $36.25
  • 52 Week High
  • NVCR $34.13
  • PHIN $57.23
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 48.61
  • PHIN 51.64
  • Support Level
  • NVCR $16.19
  • PHIN $40.36
  • Resistance Level
  • NVCR $18.52
  • PHIN $42.67
  • Average True Range (ATR)
  • NVCR 0.85
  • PHIN 1.64
  • MACD
  • NVCR 0.06
  • PHIN 0.23
  • Stochastic Oscillator
  • NVCR 54.82
  • PHIN 61.71

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About PHIN PHINIA Inc.

Phinia Inc is a leader in the development, design, and manufacture of integrated components and systems that optimize performance, increase efficiency, and reduce emissions in combustion and hybrid propulsion for commercial vehicles and industrial applications, and light vehicles. It is a global supplier to most major original equipment manufacturers (OEMs) and offers a wide range of original equipment service (OES) solutions and remanufactured products as well as an expanded range of products for the independent (non-OEM) aftermarket. Phinia has an extensive original equipment portfolio of advanced fuel injection systems, fuel delivery modules, canisters, starters, alternators, sensors, electronic control modules, and associated software.

Share on Social Networks: